Related posts:
- Nikkei earnings preview: Chinese demand seen spurring Pigeon to record first-half profit
- Sun Pharmaceutical Industries: U.S. approval boosts Indian drugmakers’ generics portfolio
- ADB president interview: No ‘significant slowdown’ in China
- Central banking: BOJ seeks to protect itself from future rising interest rates